Tumor Treating Fields; Brain metastases;
Showing 9976 - 10000 of >10,000
Cerebral Palsy Trial in Lahore (Lower Extremity Functional Training)
Recruiting
- Cerebral Palsy
- Lower Extremity Functional Training
-
Lahore, Punjab, Pakistan
- +1 more
Jul 14, 2022
Lip, Oral Cavity Squamous Cell Carcinoma, Pharynx Trial in Columbus, Philadelphia (biological, procedure, other)
Recruiting
- Lip
- +4 more
- Nivolumab
- +3 more
-
Columbus, Ohio
- +1 more
Oct 25, 2021
"Consilium" Smartphone App for Detecting Symptoms and Treatment
Terminated
- Telemedicine
- eHealth
- app
-
Feldkirch, Austria
- +17 more
Jan 31, 2022
Schizophrenia, Schizoaffective Disorder Trial in Richardson (Active anodal tDCS, Sham tDCS)
Completed
- Schizophrenia
- Schizoaffective Disorder
- Active anodal tDCS
- Sham tDCS
-
Richardson, TexasThe University of Texas at Dallas
Jun 22, 2021
Insomnia, Sleep Disturbance Trial (Saffr'Inside; 30mg, Enhanced Sleep Education, Placebo food supplement)
Not yet recruiting
- Insomnia
- Sleep Disturbance
- Saffr'Inside; 30mg
- +2 more
- (no location specified)
Mar 29, 2022
Chronic Low-back Pain Trial in Klagenfurt, Geneva (AuriMod CT01_A, AuriMod CT01_B, AuriMod CT01_C)
Completed
- Chronic Low-back Pain
- AuriMod CT01_A
- +2 more
-
Klagenfurt, Carinthia, Austria
- +1 more
Jan 30, 2023
Glioblastoma Trial in Spain (PF-04449913, Temozolomide Oral Capsule)
Active, not recruiting
- Glioblastoma
- PF-04449913
- Temozolomide Oral Capsule
-
Badalona, Barcelona, Spain
- +7 more
Feb 16, 2022
Hematological Malignancy, Cancer-Related Anemia Trial in Wuhan (Shengxuening Tablet, Ferrous succinate)
Recruiting
- Hematological Malignancy
- Cancer-Related Anemia
- Shengxuening Tablet
- Ferrous succinate
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Mar 13, 2023
Glioblastoma, Glioblastoma Multiforme Trial in Baltimore (Nivolumab, Anti-GITR Monoclonal Antibody MK-4166, IDO1 inhibitor
Terminated
- Glioblastoma
- Glioblastoma Multiforme
- Nivolumab
- +3 more
-
Baltimore, MarylandJohns Hopkins University/Sidney Kimmel Cancer Center
Jun 30, 2020
Long COVID, Long Covid19, Long Covid-19 Trial in Houston, San Antonio (BrainHQ/Active Comparator Activity, BrainHQ, PASC CoRE)
Not yet recruiting
- Long COVID
- +2 more
- BrainHQ/Active Comparator Activity
- +4 more
-
Houston, Texas
- +1 more
Aug 1, 2023
HR Positive/HER2 Low Expression Metastatic Breast Cancer Trial in Guangzhou, Shantou, Qionghai (Disitamab vedotin, Endocrine
Recruiting
- HR Positive/HER2 Low Expression Metastatic Breast Cancer
- Disitamab vedotin
- Endocrine therapy
-
Guangzhou, Guangdong, China
- +2 more
Jun 19, 2023
Traumatic Brain Injury Trial in Englewood (Augmented Reality, Treadmill training, Over ground training/standard of care)
Completed
- Traumatic Brain Injury
- Augmented Reality
- +2 more
-
Englewood, ColoradoCraig Hospital
Jan 26, 2022
Altered Neural Pain Empathic Reactivity in NSSI Adolescents
Not yet recruiting
- Nonsuicidal Self Injury
- Pain Empathy
- (no location specified)
Jul 30, 2023
Alcoholism: Emotion and Thinking
Terminated
- Alcoholism
- Magnetic Resonance Imaging (MRI)
- Interviews, cognitive tests, and emotional measurements
-
Boston, MassachusettsVA Hospital and Massachusetts General Hospital
Jul 15, 2021
NSCLC Trial in Amsterdam ([18F]F-AraG PET-scan)
Recruiting
- Non-Small Cell Lung Cancer
- [18F]F-AraG PET-scan
-
Amsterdam, Nederland, NetherlandsAmsterdam UMC, location VU University Medical Center
Jan 28, 2022
Ataxia Telangiectasia Trial in Frankfurt (Lumbar puncture)
Completed
- Ataxia Telangiectasia
- Lumbar puncture
-
Frankfurt, Hessen, GermanyJohann Wolfgang Goethe University Hospitals
Aug 30, 2021
Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III Lung
Recruiting
- Advanced Lung Non-Squamous Non-Small Cell Carcinoma
- +8 more
- Aurora A Kinase Inhibitor LY3295668
- Osimertinib
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Glioma, Malignant, Computer-Assisted Trial in Shanghai (Validation of IDH1 mutations from the radiomics model)
Active, not recruiting
- Glioma, Malignant
- Computer-Assisted
- Validation of IDH1 mutations from the radiomics model
-
Shanghai, Shanghai, ChinaHuashan Hospital, Fudan University
Jul 23, 2023
Neonatal Hypoxic-ischaemic Encephalopathy Trial in Marseille (autologous cord blood stem cell)
Recruiting
- Neonatal Hypoxic-ischaemic Encephalopathy
- autologous cord blood stem cell
-
Marseille, FranceAssistance Publique Hopitaux de Marseille
Aug 12, 2022
Familial Non-medullary Thyroid Cancer
Recruiting
- Non-Medullary Thyroid Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Atrial Fibrillation Trial in Ottawa (Apixaban, Rivaroxaban)
Recruiting
- Atrial Fibrillation
-
Ottawa, Ontario, CanadaThe Ottawa Hospital - General Campus
Mar 14, 2022
The Young Women's Breast Cancer Study
Active, not recruiting
- Breast Cancer
-
Aurora, Colorado
- +12 more
Dec 14, 2021
Cognitive Impairment in Colorectal Cancer Patients Receiving
Recruiting
- Neoplasm, Colorectal
- +7 more
-
Fort Wayne, IndianaParkview Cancer Institute
Nov 11, 2021
Moderate to Severe Traumatic Brain Injury Trial in Garches (Specific rehabilitation, Non-specific rehabilitation)
Recruiting
- Moderate to Severe Traumatic Brain Injury
- Specific rehabilitation
- Non-specific rehabilitation
-
Garches, Hauts-de-seine, FrancePhysical medicine and rehabilitation department, Raymond Poincar
May 2, 2022
Imaging SARS-CoV-2 Involvement of Leptomeninges, Olfactory and
Recruiting
- Estimate, With the Contribution of Optimized MRI, the Prevalence of Neurological and Neurovascular Manifestations on Imaging in the Event of SARS-CoV-2
- MRI
-
Paris, FranceFondation A De Rothschild
May 23, 2022